Expert Opinion on Drug Metabolism and Toxicology 2010-02-01

Antioxidant and mitochondrial protective effects of oxidized metabolites of oltipraz.

Song Hwa Choi, Young Mi Kim, Jung Min Lee, Sang Geon Kim

Index: Expert Opin. Drug Metab. Toxicol. 6(2) , 213-24, (2010)

Full Text: HTML

Abstract

Comprehensive studies indicate that oltipraz exerts cancer chemopreventive effects. Oltipraz has other therapeutic potentials, which include anti-fibrotic effect, inhibition of insulin resistance, mitochondrial protection and cytoprotective effect against oxidative stress. Although antioxidant mechanisms may account for its cancer chemopreventive effect, details on the molecular mechanism still remain to be clarified.Two major metabolic pathways of oltipraz include oxidative desulfuration of the thione to yield 4-methyl-5-(pyrazin-2-yl)-3H-1,2-dithiol-3-one and molecular rearrangement to 7-methyl-6,8-bis(methylthio)H-pyrrolo[1,2-a]pyrazine. In addition to the diverse pharmacological effects of oltipraz, the oxidized metabolites may have distinct biological effects on cell survival. The AMP-activated protein kinase pathway has been recognized as a key cascade for mitochondrial protection and cell survival events, which can be activated by the oxidized metabolites of oltipraz.In this review, the metabolic activation of oltipraz and the role of the cell signaling pathways in regulating the expression of Phase II genes and antioxidant activity are discussed with particular reference to their effects on mitochondrial protection and cell survival.In terms of therapeutic potential, the findings reviewed here demonstrate a therapeutic potential for oxidized metabolite of oltipraz and offer comparison of antioxidant capacity between metabolites and parent compound.


Related Compounds

  • Oltipraz

Related Articles:

Catalase overexpression prevents nuclear factor erythroid 2-related factor 2 stimulation of renal angiotensinogen gene expression, hypertension, and kidney injury in diabetic mice.

2014-10-01

[Diabetes 63(10) , 3483-96, (2014)]

Inhibition of colon carcinogenesis by post-initiation induction of NQO1 in Sprague-Dawley rats.

2009-06-01

[Oncol. Rep. 21(6) , 1559-65, (2009)]

Oltipraz promotion of liver regeneration after partial hepatectomy: The role of PI3-kinase-dependent C/EBPbeta and cyclin E regulation.

2009-04-01

[Arch. Pharm. Res. 32(4) , 625-35, (2009)]

Pharmacokinetic interaction between oltipraz and silymarin in rats.

2009-01-01

[J. Pharm. Pharm. Sci. 12(1) , 1-16, (2009)]

This month in APR.

2009-04-01

[Arch. Pharm. Res. 32(4) , 463-4, (2009)]

More Articles...